The new coronavirus was not developed as a biological weapon. This is the conclusion of a report on the origin of the new coronavirus released by the US intelligence community a year ago. But this week, when Bloomberg reporters traveled to Boston to learn how the U.S. intelligenc

The new coronavirus was not developed as a biological weapon. This is the conclusion of a report on the origin of the new coronavirus released by the US intelligence community a year ago.

But this week, when Bloomberg reporters went to Boston to learn how the U.S. intelligence community tracked artificial biological weapons, the reporter found more information about this conclusion.

In a report titled "How American Intelligence Personnel Know What They Know", journalist Riley Griffin wrote, "When Americans began to get infected with COVID-19 in early 2020, rumors began to suggest that it was carefully designed." David Markowitz, head of the Advanced Research Activities for Intelligence Projects (IARPA), said the outbreak of the COVID-19 outbreak was said to be a virus attack.

This agency is affiliated with the Office of the Director of National Intelligence.

It is reported that Markowitz's team has tools to determine if this is true. His institution signed a contract with synthetic biology company Ginkgo Bioengineering Corporation, academics and a nonprofit organization a few years ago. Their goal is to develop technology to detect whether an organism—including viruses, bacteria, animals or crops—has been genetically edited. These tools are designed to identify human fingerprints left in genetic password .

So when the genome sequence of the novel coronavirus (SARS-CoV-2) was first published, IARPA conducted genetic testing on one of its evolutionary tools. The platform, jointly developed by MIT and , Harvard University, gave key evidence on the virus gene instructions in just 8 minutes.

In late January 2020, before many Americans had heard of the new coronavirus, Markowitz said in a report on this analysis: "This virus shows no engineering characteristics." That is, no traces of gene editing were found.

According to reports, this gene recognition and detection technology will also develop more important scientific applications.

This Tuesday (October 18), the Biden administration of the United States announced a new national biodefense strategy, which provides clearer instructions on how to defend against biological threats ranging from naturally occurring infectious diseases to artificial weapons of mass destruction. The strategic framework seeks to better define government responsibilities, goals and deadlines in crisis and put White House at the center of response.

One of the goals of the Biden administration is to identify and hold bad actors accountable when developing and using biological weapon . , the gene technology developed by IARPA, is helping this.

"Nationalist countries and terrorist organizations have discovered the value of developing biological weapons," warned the U.S. National Biodefense Strategy, "This dangerous trend will not change in the future."